Marc Mansour

This inventor holds 16 USPTO granted patents and 7 published patent applications, plus 21 CIPO patents and 6 EPO patents. Top assignees: Immunovaccine Technologies Inc., Biovaxys Inc.. Active years: 2006-2024.

USPTO Granted Patents = 16 (Patent Applications = 7)

% Patents Active = 68.8

CIPO Patents = 21 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 62(Granted Patents)

Company Filing History:

15 out of 20

Immunovaccine Technologies Inc.

Years Active: 2006-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12042537 - Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjects (2024-07-23),

2. 11717563 - Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance (2023-08-08),

3. 11406705 - Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjects (2022-08-09),

4. 11235069 - Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo (2022-02-01),

5. 11160861 - Adjuvanting systems and water-free vaccine compositions comprising a polyI:C polynucleotide adjuvant and a lipid-based adjuvant (2021-11-02),

6. 11077184 - Liposome compositions comprising PAM2Cys or PAM3Cys adjuvant and methods for inducing a humoral immune response (2021-08-03),

7. 10988500 - Lipid A mimics, methods of preparation, and uses thereof (2021-04-27),

8. 10729766 - Method for improving the efficacy of a survivin vaccine in the treatment of cancer (2020-08-04),

9. 10533033 - Lipid A mimics, methods of preparation, and uses thereof (2020-01-14),

10. 10272042 - Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment (2019-04-30),

11. 10232052 - Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo (2019-03-19),

12. 10105435 - Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof (2018-10-23),

13. 10022441 - Method for improving the efficacy of a survivin vaccine in the treatment of cancer (2018-07-17),

14. 9925142 - Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment (2018-03-27),

15. 9498493 - Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo (2016-11-22),

Title: Marc Mansour - Innovator from Halifax, CA

Introduction: Marc Mansour is a renowned inventor hailing from Halifax, Canada, known for his groundbreaking contributions to various fields.

Latest Patents: Marc Mansour holds several patents in the areas of renewable energy technologies, medical devices, and sustainable materials.

Career Highlights: With a career spanning over two decades, Marc Mansour has worked with leading research institutions and companies to develop innovative solutions that have had a significant impact on society.

Collaborations: Throughout his career, Marc Mansour has collaborated with top universities, research institutions, and companies worldwide to bring his inventions to life and make a difference in the world.

Conclusion: Marc Mansour's dedication to innovation and his passion for creating solutions to complex problems have solidified his reputation as a visionary inventor in the global innovation landscape.